严重急性呼吸综合征冠状病毒2型疫苗的安全性与自身免疫反应
SARS-CoV-2 Vaccine Safety and Autoimmune Response.
作者信息
Tyan Yu-Chang, Chuang Shih-Chang, Ho Tzu-Chuan, Chuang Kuo-Pin, Yang Ming-Hui
机构信息
Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
出版信息
Vaccines (Basel). 2024 Mar 20;12(3):334. doi: 10.3390/vaccines12030334.
Abstract
Coronavirus disease 2019 (COVID-19) is a global public health crisis [...].
摘要
2019冠状病毒病（COVID-19）是一场全球公共卫生危机[……]。
相似文献
1
SARS-CoV-2 Vaccine Safety and Autoimmune Response.
Vaccines (Basel). 2024 Mar 20;12(3):334. doi: 10.3390/vaccines12030334.
2
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
3
COVID-19 Vaccine Platforms: Challenges and Safety Contemplations.
Vaccines (Basel). 2021 Oct 18;9(10):1196. doi: 10.3390/vaccines9101196.
4
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
5
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
6
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Infect Disord Drug Targets. 2021;21(4):541-552. doi: 10.2174/1871526520666200921154149.
7
Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
BMC Endocr Disord. 2023 Feb 22;23(1):47. doi: 10.1186/s12902-023-01296-4.
8
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity.
Vaccine. 2022 Jul 30;40(32):4440-4452. doi: 10.1016/j.vaccine.2022.05.087. Epub 2022 Jun 6.
9
Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs.
mBio. 2021 Oct 26;12(5):e0190821. doi: 10.1128/mBio.01908-21. Epub 2021 Sep 21.
10
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
Toxicol Pathol. 2020 Oct;48(7):800-809. doi: 10.1177/0192623320959090. Epub 2020 Sep 14.
引用本文的文献
1
New-onset drug-resistant epilepsy in type 1 diabetes mellitus patient following COVID-19 vaccination: suspicious for autoimmune pathogenesis.
BMC Neurol. 2025 Jun 19;25(1):251. doi: 10.1186/s12883-025-04126-3.
本文引用的文献
1
Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders.
J Clin Med. 2024 Feb 9;13(4):1012. doi: 10.3390/jcm13041012.
2
Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective study.
EBioMedicine. 2024 Jan;99:104912. doi: 10.1016/j.ebiom.2023.104912. Epub 2023 Dec 13.
3
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort.
Rheumatol Int. 2023 Dec;43(12):2211-2220. doi: 10.1007/s00296-023-05441-z. Epub 2023 Sep 15.
4
COVID-19 and herpes zoster: a call to action.
Front Public Health. 2023 Aug 10;11:1200353. doi: 10.3389/fpubh.2023.1200353. eCollection 2023.
5
Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study.
EClinicalMedicine. 2023 Aug 16;63:102154. doi: 10.1016/j.eclinm.2023.102154. eCollection 2023 Sep.
6
Common Side Effects of Pfizer COVID-19 Vaccine: An Experience From Pakistan.
Cureus. 2023 Jun 23;15(6):e40878. doi: 10.7759/cureus.40878. eCollection 2023 Jun.
7
Insights into new-onset autoimmune diseases after COVID-19 vaccination.
Autoimmun Rev. 2023 Jul;22(7):103340. doi: 10.1016/j.autrev.2023.103340. Epub 2023 Apr 17.
8
Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination.
Vaccines (Basel). 2023 Mar 17;11(3):696. doi: 10.3390/vaccines11030696.
9
Varicella zoster virus reactivation following COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases.
J Med Virol. 2023 Jan;95(1):e28307. doi: 10.1002/jmv.28307. Epub 2022 Nov 21.
10
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection.
J Biomed Sci. 2022 Oct 15;29(1):82. doi: 10.1186/s12929-022-00853-8.
Zotero 插件